JPMorgan Financial prices $3.09M buffered enhanced notes
JPMorgan Chase Financial Company LLC priced $3,090,000 of Uncapped Buffered Return Enhanced Notes due March 2, 2029.
JPMorgan Chase Financial Company LLC priced $3,090,000 of Uncapped Buffered Return Enhanced Notes due March 2, 2029. The notes pay 1.63× any appreciation of the least performing of the Dow Jones Industrial Average®, the Russell 2000® Index and the S&P 500® Index at maturity, subject to a 10.00% buffer. Investors receive principal at maturity if losses on the least performing Index do not exceed 10.00%; if the least performing Index declines by more than 10.00%, investors lose 1% of principal for each additional 1% decline, up to a 90.00% loss. The notes priced on February 27, 2026 and are expected to settle on or about March 4, 2026, with an observation date of February 27, 2029. Payments are obligations of JPMorgan Chase Financial Company LLC and are fully and unconditionally guaranteed by JPMorgan Chase & Co.; any payments are subject to both entities' credit risk.
Positive
- None.
Negative
- None.
Insights
Product combines leveraged upside on the weakest index with a 10% downside buffer but substantial principal risk.
The notes offer an Upside Leverage Factor of 1.63 on the Least Performing Index Return and a 10.00% Buffer, meaning limited protection only within that buffer and magnified upside if all indices finish higher. The pricing supplement shows an original issue price of $1,000 and an estimated value of $966.20 per $1,000 note when terms were set.
Key dependencies are the relative paths of the three indices to February 27, 2026 initial levels and issuer credit. Secondary market liquidity and repurchase pricing are limited; the initial repurchase credit feature may decline over an initial predetermined period (shorter of six months and half the term), per the supplement.
Tax treatment may be that of an "open transaction"; this is opinion-based and not guaranteed.
Special tax counsel opines the notes may be treated as open transactions not characterized as debt, which could result in long-term capital gain or loss if held over one year. That treatment depends on existing tax rules and is not binding on the IRS.
Section 871(m) considerations are addressed; the issuer concluded that Section 871(m) should not apply for Non-U.S. Holders, but the IRS could disagree. Holders should consult their tax advisers regarding these opinions and potential alternate treatments.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What amount was offered in this AMJB offering?
How is the payment at maturity determined for AMJB notes?
Who bears credit risk for these AMJB notes?
Will I receive dividends or interest on AMJB notes?
Can I sell the AMJB notes before maturity?
AI-generated analysis. How Rhea-AI works. Not financial advice.